PA
VIAV icon

PharVision Advisers’s Viavi Solutions VIAV Stock Holding History

PharVision Advisers’s Portfolio VIAV Stock Details VIAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,510
Closed -$187K – 629
2025
Q4 		$187K Buy
+10,510
New +$170K 0.09% 585
2025
Q2 		– Sell
-29,702
Closed -$332K – 439
2025
Q1 		$332K Buy
+29,702
New +$330K 0.46% 78

Other funds holding VIAV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

PharVision Advisers's VIAV Position: Q1 2026 in Review

PharVision Advisers sold out of Viavi Solutions (VIAV) in Q1 2026, closing a stake of 10,510 shares — an estimated $187K sold.

PharVision Advisers first reported a position in VIAV in Q1 2025 and held it in 2 quarters. The position peaked at $332K in Q1 2025. 465 funds tracked by Wall St. Rank hold VIAV as of Q1 2026.

  • PharVision Advisers reported no remaining Viavi Solutions position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 10,510 Viavi Solutions shares in Q1 2026, an estimated $187K.
  • PharVision Advisers first reported a position in Viavi Solutions in Q1 2025 and held it in 2 quarters.
  • PharVision Advisers's Viavi Solutions position peaked at $332K in Q1 2025.
  • 465 funds tracked by Wall St. Rank held Viavi Solutions as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.